These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20675993)

  • 1. [EUROASPIRE III: a comparison between Turkey and Europe].
    Tokgözoğlu L; Kaya EB; Erol C; Ergene O;
    Turk Kardiyol Dern Ars; 2010 Apr; 38(3):164-72. PubMed ID: 20675993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of overweight and obese patients with coronary heart disease across Europe.
    De Bacquer D; Dallongeville J; Heidrich J; Kotseva K; Reiner Z; Gaita D; Prugger C; Wellmann J; Wood D; De Backer G; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):447-54. PubMed ID: 20485181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey.
    Prugger C; Keil U; Wellmann J; de Bacquer D; de Backer G; Ambrosio GB; Reiner Z; Gaita D; Wood D; Kotseva K; Heidrich J;
    J Hypertens; 2011 Aug; 29(8):1641-8. PubMed ID: 21720270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region of Münster, Germany].
    Heidrich J; Liese AD; Kalic M; Winter-Enbergs A; Wellmann J; Roeder N; Kerber S; Breithardt G; Scheld HH; Kleine-Katthöfer P; Keil U
    Dtsch Med Wochenschr; 2002 Mar; 127(13):667-72. PubMed ID: 11928058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pursuit of secondary prevention targets in Czech coronary patients. A comparison of EuroAspire I and II surveys.
    Mayer O; Simon J; Rosolová H; De Bacquer D;
    Cent Eur J Public Health; 2002 Sep; 10(3):107-11. PubMed ID: 12298341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of coronary artery disease in Kyrgyzstan: a comparison with Turkey and europe according to European Action on Primary and secondary prevention by intervention to reduce events III results.
    Kutlu R; Muratalievic TM; Memetoglu ME
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):545-52. PubMed ID: 25362945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey.
    van Berkel TF; Boersma H; De Baquer D; Deckers JW; Wood D
    Eur Heart J; 1999 Nov; 20(22):1630-7. PubMed ID: 10543926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
    Dallongevillle J; De Bacquer D; Heidrich J; De Backer G; Prugger C; Kotseva K; Montaye M; Amouyel P;
    Heart; 2010 Nov; 96(21):1744-9. PubMed ID: 20956490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].
    Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Tulunay Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):134-144. PubMed ID: 28424435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey.
    De Smedt D; Clays E; Annemans L; Doyle F; Kotseva K; Pająk A; Prugger C; Jennings C; Wood D; De Bacquer D
    Int J Cardiol; 2013 Sep; 168(2):898-903. PubMed ID: 23201081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
    EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
    Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking behaviour in European patients with established coronary heart disease.
    Scholte op Reimer W; de Swart E; De Bacquer D; Pyörälä K; Keil U; Heidrich J; Deckers JW; Kotseva K; Wood D; Boersma E
    Eur Heart J; 2006 Jan; 27(1):35-41. PubMed ID: 16210309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].
    Ostör E; Jánosi A; Belatiny KA; Borbás S; Bradak A; Podmaniczky M
    Orv Hetil; 1999 Jan; 140(5):243-8. PubMed ID: 10064978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
    Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
    Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking prevalence in coronary patients from EuroAspire III Romania.
    Crăciun L; Avram A; Iurciuc S; Sarău C; Avram C; Căprariu M; Gojka G; Gaiţă D; Mancaş S
    Pneumologia; 2009; 58(3):190-4. PubMed ID: 19817318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
    Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
    Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.